Palakkad (Kerala) (PTI): Prime Minister Narendra Modi will arrive in Kerala on Sunday to lead a rally in Palakkad and a roadshow in Thrissur, as he joins the campaign trail for NDA candidates ahead of the April 9 Assembly elections.
Hours ahead of his visit, Modi said in a social media post that the "mood of Keralam" is in favour of the BJP-led NDA.
The people of the state have had enough of the poor governance of the LDF and the UDF, he said in a post on 'X'.
Thousands of party workers are expected to participate in a public meeting to be addressed by Modi at Fort Maidan in Palakkad by around 2.30 pm, party sources said.
ALSO READ: Raichur: Two killed after bike rams stationary lorry
The rally is expected to witness the participation of senior BJP leaders and NDA candidates from the region.
Later in the day, the prime minister will travel to neighbouring Thrissur, where he is slated to hold a massive roadshow in the heart of the city, they said.
He will be received by Union Minister Suresh Gopi and other party leaders when he lands at a helipad in Kuttanellur in Thrissur.
From there, the prime minister will proceed to the Swaraj Round to lead the roadshow.
Traffic regulations are in place in both Palakkad and Thrissur in view of the PM's visit.
"Looking forward to being among the people of Keralam later today. Will address a rally in Palakkad and later will take part in a roadshow in Thrissur. The mood of Keralam is in favour of the NDA. The people have had enough of the poor governance of LDF and UDF," Modi said in the post on 'X'.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi: India reported an estimated 2.7 million tuberculosis cases in 2025 which translates into an incidence of 185 cases per 100,000 population, according to the latest official update on the disease burden.
The figure is more than four times the elimination benchmark set under the National Strategic Plan for Tuberculosis. The plan had aimed to bring down incidence to 44 cases per 100,000 population and mortality to three per 100,000 by 2025. The target was announced in March 2017 and was set five years ahead of the global End TB goals and the UN Sustainable Development Goals.
Data indicate that TB notifications have increased by 13 per cent compared to pre-Covid levels, as IndiaSpend reported in July 2025. Public health experts have said higher notification does not necessarily reflect a rise in incidence, but indicate improved case detection. Authorities have stepped up efforts to improve reporting and plug gaps in diagnosis and treatment, under the National Tuberculosis Elimination Programme (NTEP).
According to a 2019 study published in PLOS Medicine, the most substantial gap occurs during the testing stage, with nearly half of those with incident tuberculosis not receiving diagnostic tests. Experts say stigma, restricted availability to molecular testing, and dependence on sputum microscopy continue to impede early detection.
According to official data, 19.3 million smear microscopy tests were performed in 2023, compared to 6.83 million molecular tests using the CBNAAT/GeneXpert and Truenat platforms, indicating that smear-based diagnosis will continue to be used. While doctors report inconsistent implementation across regions, legislation mandates 100% molecular testing for suspected tuberculosis patients.
Health officials point to the increase of diagnostic infrastructure, which includes approximately 10,000 Nucleic Acid Amplification Test equipment and over 25,000 microscopy centers across the country. Eexperts identify operational difficulties such as specimen transportation, machine maintenance, supplier chains, and unequal distribution of skilled staff.
Under the TB-Mukt Bharat Abhiyan, the government has expanded active case-finding in high-risk areas and identified 1.58 lakh vulnerable villages and urban wards using an AI-based mapping tool. Under which the latest campaign document states that of the 2.73 million cases reported in 2025, 35 per cent were asymptomatic.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
Specialists warn that up to half of microbiologically diagnosed pulmonary tuberculosis patients may not show characteristic symptoms, contributing to continuous community transmission. To increase early diagnosis of drug resistance, it is advised that chest X-rays and molecular testing be used more frequently.
The government increased financial aid for Tuberculosis patients under the Nikshay Poshan Yojana to ₹1,000 per month, as the disease is mostly linked with malnutrition and poor living conditions and those with a BMI less than 18.5 are given energy-dense nutritional supplements for the first two months of therapy.
